Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study.
Valerio NardoneAlessio BruniDavide FranceschiniBeatrice MariniStefano VaggePatrizia CiammellaMatteo SepulcriAnna CappelliElisa D'AngeloGiuseppina De MarcoAntonio AngrisaniMattia ManettaMelissa ScriccioloCesare GuidaDario AielloPaolo BorghettiSalvatore CappabiancaPublished in: La Radiologia medica (2024)
RAC-TAC retrospective multicentric study showed the low toxicity of PORT when advanced technology is used. At the same time, it's noteworthy to underline that 50% of the patients develop distant recurrences in the follow up.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- prognostic factors
- newly diagnosed
- early stage
- small cell lung cancer
- lymph node
- peritoneal dialysis
- squamous cell carcinoma
- clinical trial
- intensive care unit
- cross sectional
- randomized controlled trial
- liver failure
- patient reported outcomes
- spinal cord injury
- radiation induced
- locally advanced